How can ophthalmologists better educate patients about the severity of DME progression?
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Geographic and institutional disparities identified in DR and DME clinical trials
Racial disparities in visual outcomes of ranibizumab-treated DME
Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200
FDA approves expanded label for fluocinolone acetonide intravitreal implant
Unity Biotechnology Inc appoints Yehia Hashad, MD, to the board of directors and science committee